Rosenberg T, Möller S, Abildgaard N, Nørgaard JN, Lysén A, Tsykonova G, Joao C, Vangsted A, Schjesvold F, Nielsen LK(2024) Health-Related Quality of Life During Carfilzomib-Lenalidomide-Dexamethasone Consolidation: Findings From the Multiple Myeloma CONPET Study Eur J Haematol(in press) DOI 10.1111/ejh.14358, PubMed 39638553
Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE(2024) Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy Clin Lymphoma Myeloma Leuk(in press) DOI 10.1016/j.clml.2024.10.005, PubMed 39500643
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted Aet al.(2024) A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma Future Oncol, 20(38), 3043-3063 DOI 10.1080/14796694.2024.2394323, PubMed 39287147
